Kenneth Pettine, MD, is an orthopedic spine surgeon at Loveland (Colo.) Surgery Center. He is co-founder of Rocky Mountain Associates in Orthopedic Medicine and the co-inventor and co-designer of the Maverick Artificial Disc, a patented disc replacement device for the neck and back. The device is currently undergoing a clinical trial.
Dr. Pettine was among the first spine surgeons to perform a minimally invasive lumbar disc procedure using Mesoblast technology. The procedure was performed in a Phase 2 clinical trial of the adult Mesenchymal Precursor Cell product for treating patients with low back pain and degenerative disc disease.
Dr. Pettine specializes in spinal surgery, research and rehabilitation. He is a member of American Academy of Orthopaedic Surgeons, North American Spine Society and the Arthroscopy Association of North America.
"I remain most excited the last two and a half years of being involved in two FDA studies involving biologics to treat discogenic low back pain," said Dr. Pettine in a Becker's Spine Review article. "In addition we have injected over 130 patients with autogenous bone marrow concentrate. I believe biologics will soon change the practice of spine and am excited to be pioneering this advancement."
Dr. Pettine earned his medical degree at the University of Colorado School of Medicine in Denver. He completed his residency at Mayo Clinic in Rochester, Minn., and his fellowship training at Institute for Low Back Care in Minneapolis.
Dr. Pettine will be speaking at 11th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference in June 2013. He will be speaking about the latest development in stem cell treatments as applied to spine and about key concepts to improve the profitability and outcomes of spine programs.
Spine Surgeon Leader to Know: Dr. Wayne Cheng of Loma Linda University Orthopaedic Group
Spine Surgeon Leader to Know: Dr. William Abdu of Dartmouth-Hitchcock Medical Center
Dr. Pettine was among the first spine surgeons to perform a minimally invasive lumbar disc procedure using Mesoblast technology. The procedure was performed in a Phase 2 clinical trial of the adult Mesenchymal Precursor Cell product for treating patients with low back pain and degenerative disc disease.
Dr. Pettine specializes in spinal surgery, research and rehabilitation. He is a member of American Academy of Orthopaedic Surgeons, North American Spine Society and the Arthroscopy Association of North America.
"I remain most excited the last two and a half years of being involved in two FDA studies involving biologics to treat discogenic low back pain," said Dr. Pettine in a Becker's Spine Review article. "In addition we have injected over 130 patients with autogenous bone marrow concentrate. I believe biologics will soon change the practice of spine and am excited to be pioneering this advancement."
Dr. Pettine earned his medical degree at the University of Colorado School of Medicine in Denver. He completed his residency at Mayo Clinic in Rochester, Minn., and his fellowship training at Institute for Low Back Care in Minneapolis.
Dr. Pettine will be speaking at 11th Annual Orthopedic, Spine and Pain Management-Driven ASC Conference in June 2013. He will be speaking about the latest development in stem cell treatments as applied to spine and about key concepts to improve the profitability and outcomes of spine programs.
More Articles on Spine Leaders:
Spine Surgeon Leader to Know: Dr. Paul Anderson of University of Wisconsin-Madison Health – Research Park ClinicSpine Surgeon Leader to Know: Dr. Wayne Cheng of Loma Linda University Orthopaedic Group
Spine Surgeon Leader to Know: Dr. William Abdu of Dartmouth-Hitchcock Medical Center